Medical News

RSS

Today's opinions and editorials

When conservatives scream about socialized medicine and death panels, you should tune them out. But lately conservatives have been making an argument you should hear. It's about whether we can believe Congress when it promises to raise taxes or cut spending--and, as such, whether we can believe that health care reform can actually be fiscally responsible (Jonathan Cohn, 11/2).

2 Nov 2009

Cyberonics to develop medical devices with cutting edge technology for persons suffering from epilepsy

Cyberonics, Inc. today announced another in a series of collaborations around seizure detection technology aimed at advancing its development of new and more efficacious medical devices for persons suffering from epilepsy.

2 Nov 2009

EnzymeRx commences patient enrollment in Uricase-PEG 20 phase 1 study

EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, announced that it has launched its first clinical study of Uricase-PEG 20. Subjects have begun enrolling in a phase 1 safety, pharmacokinetic and pharmacodynamic study of single intravenous doses of Uricase-PEG 20.

2 Nov 2009

Heart, cancer doctors get break on scheduled Medicare pay cuts

Heart and cancer doctors will get a smaller fee cut next year from Medicare, the U.S. government program for the elderly, than the Obama administration first sought in a move to shift money to family physicians," Bloomberg reports. Earlier this year, Medicare officials said they would cut 10 percent of payments for the two specialties. Now, they plan on making the reductions over four years, instead.

2 Nov 2009

The Clorox Company anounces fiscal 2010 first-quarter results

The Clorox Company today reported strong earnings growth, driven by robust gross margin expansion and modest volume growth, for its first quarter, which ended Sept. 30.

2 Nov 2009

CBO: Few Americans would sign up for public health insurance plan

The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."

2 Nov 2009

Health Dialog's initiative to build a health center in rural Ecuador

Building on its commitment to improving health globally, Health Dialog is participating in a volunteer initiative to build a vital health center in the small town of Miraflores, Ecuador, where a doctor visits only six times a year because of the remote location.

2 Nov 2009

Obama's health reform political maneuvers may prove successful

"After months of plodding work by five Congressional committees and weeks of back-room bargaining by Democratic leaders, President Obama's arms-length strategy on health care appears to be paying dividends, with the House and the Senate poised to take up legislation to insure nearly all Americans," The New York Times reports.

2 Nov 2009

Aribex alleges patent infringement of its handheld X-ray, files a complaint against Bio-Ray Prox

Aribex, Inc., of Orem, Utah, today announced that it has filed a patent infringement complaint for unspecified damages against manufacturer DigiMed Co., Ltd (of Seoul, Korea), Sigma Biomedics (of Buffalo Grove, Illinois), and Dentalaire Products (of Fountain Valley, Calif.). Sigma and Dentalaire distribute the Bio-Ray Prox, a portable X-ray device which is manufactured in Korea by DigiMed.

2 Nov 2009

States will implement many health reform initiatives

"The debate over whether to let states opt out of any government-run health insurance plan overlooks a key facet of the health-care measures being assembled in Congress: When Washington is done, the shape of any new health-care system is likely to be finalized in Lansing and Boise and Baton Rouge," The Washington Post reports.

2 Nov 2009

2009 EACTS Techno-College Innovation Award to Clear Catheter Systems for its PleuraFlow system

Clear Catheter Systems, a private medical device company pioneering proprietary medical catheter anti-occlusion technologies, has been awarded the 2009 EACTS Techno-College Innovation Award for its PleuraFlow Active Tube Clearance System. The Techno-College Award is a worldwide competition to identify innovations with the potential to change the standard of care in heart and lung surgery.

2 Nov 2009

DSPA chooses SAS Solutions OnDemand as a technology platform for clinical development

SAS announced today that Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. pharmaceutical company, has selected SAS Solutions OnDemand: Drug Development as a technology platform for clinical development. With SAS OnDemand, DSPA will have a globally accessible, fully regulatory compliant repository for all of its clinical data.

2 Nov 2009

Online interactive pancreatic cancer awareness campaign launched

In recognition of National Pancreatic Cancer Awareness Month, the Pancreatic Cancer Action Network is issuing a challenge to increase the number of people aware of the deadly disease through an online interactive campaign "Pancreatic Cancer: Know it. Fight it. End it."

2 Nov 2009

SQI Diagnostics' SQiDworks automated platform and IgXPLEX RA assay receive FDA marketing clearance

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.

2 Nov 2009

MDS sells its Central Labs operations to Czura Thornton

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has completed the divestiture of its Central Labs operations to Czura Thornton, a private investment group based in Jersey, Channel Islands.

From Danaher 2 Nov 2009

FDA issues a Complete Response Letter for GTx' toremifene NDA

GTx, Inc. today announced that it has received a Complete Response Letter issued by the United States Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for toremifene 80 mg to reduce fractures in men with prostate cancer receiving androgen deprivation therapy (ADT).

2 Nov 2009

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

ZirMed®, a national provider of revenue cycle management services for healthcare practices, and leading integrated healthcare technology company Raintree Systems Inc. today announced a working partnership to jointly market their combined solutions to current and prospective customers. As a result of the partnership, ZirMed's flagship revenue cycle management platform will be integrated with Raintree's practice management and Electronic Medical Records (EMR) products, giving users state-of-the-art technology with which to better manage their daily operations.

2 Nov 2009

Juvaris BioTherapeutics commences enrollment in its JVRS-100 influenza vaccine adjuvant study

Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, today announced that it has begun enrolling patients in a Phase 2 clinical trial of its lead compound, JVRS-100, as an adjuvant for seasonal influenza vaccines in the elderly population.

2 Nov 2009

Artificial Medical Intelligence releases enhanced EMscribe CAC software

Artificial Medical Intelligence (AMI) today announced its newly enhanced EMscribe™ Computer Assisted Coding (CAC) software, version 4.0.

2 Nov 2009

Sunesis Pharmaceuticals raises $5.0 million through private placement

Sunesis Pharmaceuticals, Inc. today announced the closing of a private placement of $5.0 million of units consisting of convertible preferred stock and common stock warrants on October 30, 2009. This closing constitutes the second tranche of the private placement of up to $43.5 million of Sunesis' securities announced in April 2009.

2 Nov 2009

Medical News

Today's opinions and editorials

Cyberonics to develop medical devices with cutting edge technology for persons suffering from epilepsy

EnzymeRx commences patient enrollment in Uricase-PEG 20 phase 1 study

Heart, cancer doctors get break on scheduled Medicare pay cuts

The Clorox Company anounces fiscal 2010 first-quarter results

CBO: Few Americans would sign up for public health insurance plan

Health Dialog's initiative to build a health center in rural Ecuador

Obama's health reform political maneuvers may prove successful

Aribex alleges patent infringement of its handheld X-ray, files a complaint against Bio-Ray Prox

States will implement many health reform initiatives

2009 EACTS Techno-College Innovation Award to Clear Catheter Systems for its PleuraFlow system

DSPA chooses SAS Solutions OnDemand as a technology platform for clinical development

Online interactive pancreatic cancer awareness campaign launched

SQI Diagnostics' SQiDworks automated platform and IgXPLEX RA assay receive FDA marketing clearance

MDS sells its Central Labs operations to Czura Thornton

FDA issues a Complete Response Letter for GTx' toremifene NDA

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

Juvaris BioTherapeutics commences enrollment in its JVRS-100 influenza vaccine adjuvant study

Artificial Medical Intelligence releases enhanced EMscribe CAC software

Sunesis Pharmaceuticals raises $5.0 million through private placement

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News